{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T22:01:25Z","timestamp":1768773685958,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000001","name":"alberta cancer foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000001","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009009","name":"Novartis Pharmaceuticals Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009009","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Olav Raagholt og Gerd Meidel Raagholts stiftelse for forskning"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00280-020-04213-x","type":"journal-article","created":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T11:14:51Z","timestamp":1609845291000},"page":"259-267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Enhancing the activity of platinum-based drugs by improved inhibitors of ERCC1\u2013XPF-mediated DNA repair"],"prefix":"10.1007","volume":"87","author":[{"given":"Gloria","family":"Ciniero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed H.","family":"Elmenoufy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Weinfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.","family":"Deriu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick G.","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack A.","family":"Tuszynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Dumontet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emeline","family":"Cros-Perrial","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3948-7090","authenticated-orcid":false,"given":"Lars Petter","family":"Jordheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"4213_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.isci.2019.05.017","volume":"16","author":"S Li","year":"2019","unstructured":"Li S, Lu H, Wang Z, Hu Q, Wang H, Xiang R, Chiba T, Wu X (2019) ERCC1\/XPF is important for repair of dna double-strand breaks containing secondary structures. iScience 16:63\u201378. https:\/\/doi.org\/10.1016\/j.isci.2019.05.017","journal-title":"iScience"},{"key":"4213_CR2","doi-asserted-by":"publisher","first-page":"10181","DOI":"10.1093\/nar\/gkz769","volume":"47","author":"H Zhang","year":"2019","unstructured":"Zhang H, Chen Z, Ye Y, Ye Z, Cao D, Xiong Y, Srivastava M, Feng X, Tang M, Wang C, Tainer JA, Chen J (2019) SLX4IP acts with SLX4 and XPF\u2013ERCC1 to promote interstrand crosslink repair. Nucleic Acids Res 47:10181\u201310201. https:\/\/doi.org\/10.1093\/nar\/gkz769","journal-title":"Nucleic Acids Res"},{"key":"4213_CR3","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.3390\/molecules23123205","volume":"23","author":"M Faridounnia","year":"2018","unstructured":"Faridounnia M, Folkers GE, Boelens R (2018) Function and interactions of ERCC1\u2013XPF in DNA damage response. Molecules 23:3205. https:\/\/doi.org\/10.3390\/molecules23123205","journal-title":"Molecules"},{"key":"4213_CR4","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.3390\/nu10111644","volume":"10","author":"JR Heyza","year":"2018","unstructured":"Heyza JR, Arora S, Zhang H, Conner KL, Lei W, Floyd AM, Deshmukh RR, Sarver J, Trabbic CJ, Erhardt P, Chan TH, Dou QP, Patrick SM (2018) Targeting the DNA repair endonuclease ERCC1\u2013XPF with green tea polyphenol epigallocatechin-3-gallate (EGCG) and its prodrug to enhance cisplatin efficacy in human cancer cells. Nutrients 10:1644. https:\/\/doi.org\/10.3390\/nu10111644","journal-title":"Nutrients"},{"key":"4213_CR5","doi-asserted-by":"publisher","first-page":"9990","DOI":"10.1093\/nar\/gks818","volume":"40","author":"EM McNeil","year":"2012","unstructured":"McNeil EM, Melton DW (2012) DNA repair endonuclease ERCC1\u2013XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy. Nucleic Acids Res 40:9990\u201310004. https:\/\/doi.org\/10.1093\/nar\/gks818","journal-title":"Nucleic Acids Res"},{"key":"4213_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.bcp.2006.04.025","volume":"72","author":"M Cummings","year":"2006","unstructured":"Cummings M, Higginbottom K, McGurk CJ, Wong OGW, K\u00f6berle B, Oliver RTD, Masters JR (2006) XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair. Biochem Pharmacol 72:166\u2013175. https:\/\/doi.org\/10.1016\/j.bcp.2006.04.025","journal-title":"Biochem Pharmacol"},{"key":"4213_CR7","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.bbrc.2004.12.008","volume":"327","author":"IY Chang","year":"2005","unstructured":"Chang IY, Kim MH, Kim HB, Lee DY, Kim SH, Kim HY, You HJ (2005) Small interfering RNA-induced suppression of ERCC1 enhances sensitivity of human cancer cells to cisplatin. Biochem Biophys Res Commun 327:225\u2013233. https:\/\/doi.org\/10.1016\/j.bbrc.2004.12.008","journal-title":"Biochem Biophys Res Commun"},{"key":"4213_CR8","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.dnarep.2010.03.010","volume":"9","author":"S Arora","year":"2010","unstructured":"Arora S, Kothandapani A, Tillison K, Kalman-Maltese V, Patrick SM (2010) Downregulation of XPF-ERCC1 enhances cisplatin efficacy in cancer cells. DNA Repair (Amst) 9:745\u2013753. https:\/\/doi.org\/10.1016\/j.dnarep.2010.03.010","journal-title":"DNA Repair (Amst)"},{"key":"4213_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1124\/mol.112.082347","volume":"84","author":"LP Jordheim","year":"2013","unstructured":"Jordheim LP, Barakat KH, Heinrich-Balard L, Matera EL, Cros-Perrial E, Bouledrak K, El SR, Perez-Pineiro R, Wishart DS, Cohen R, Tuszynski J, Dumontet C (2013) Small molecule inhibitors of ERCC1\u2013XPF protein\u2013protein interaction synergize alkylating agents in cancer cellss. Mol Pharmacol 84:12\u201324. https:\/\/doi.org\/10.1124\/mol.112.082347","journal-title":"Mol Pharmacol"},{"key":"4213_CR10","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/cbdd.13660","volume":"95","author":"F Gentile","year":"2020","unstructured":"Gentile F, Elmenoufy AH, Ciniero G, Jay D, Karimi-Busheri F, Barakat KH, Weinfeld M, West FG, Tuszynski JA (2020) Computer-aided drug design of small molecule inhibitors of the ERCC1\u2013XPF protein\u2013protein interaction. Chem Biol Drug Des 95:460\u2013471. https:\/\/doi.org\/10.1111\/cbdd.13660","journal-title":"Chem Biol Drug Des"},{"key":"4213_CR11","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.tig.2014.06.003","volume":"30","author":"F Dietlein","year":"2014","unstructured":"Dietlein F, Thelen L, Reinhardt HC (2014) Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches. Trends Genet 30:326\u2013339. https:\/\/doi.org\/10.1016\/j.tig.2014.06.003","journal-title":"Trends Genet"},{"key":"4213_CR12","first-page":"173","volume":"2","author":"JM Hill","year":"1982","unstructured":"Hill JM, Speer RJ (1982) Organo-platinum complexes as antitumor agents. (Review). Anticancer Res 2:173\u2013185","journal-title":"Anticancer Res"},{"key":"4213_CR13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, Chan FKM, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D\u2019Angiolella V, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, Deberardinis RJ, Deshmukh M, Di Daniele N, Di Virgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, El-Deiry WS, Elrod JW, Fimia GM, Fulda S, Garc\u00eda-S\u00e1ez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, Hengartner MO, Hetz C, Ichijo H, J\u00e4\u00e4ttel\u00e4 M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, Lee SW, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, L\u00f3pez-Ot\u00edn C, Lowe SW, Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine JC, Martin SJ, Martinou JC, Medema JP, Mehlen P, Meier P, Melino S, Miao EA, Molkentin JD, Moll UM, Mu\u00f1oz-Pinedo C, Nagata S, Nu\u00f1ez G, Oberst A, Oren M, Overholtzer M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pereira DM, Pervaiz S, Peter ME, Piacentini M, Pinton P, Prehn JHM, Puthalakath H, Rabinovich GA, Rehm M, Rizzuto R, Rodrigues CMP, Rubinsztein DC, Rudel T, Ryan KM, Sayan E, Scorrano L, Shao F, Shi Y, Silke J, Simon HU, Sistigu A, Stockwell BR, Strasser A, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Thorburn A, Tsujimoto Y, Turk B, Vanden Berghe T, Vandenabeele P, Vander Heiden MG, Villunger A, Virgin HW, Vousden KH, Vucic D, Wagner EF, Walczak H, Wallach D, Wang Y, Wells JA, Wood W, Yuan J, Zakeri Z, Zhivotovsky B, Zitvogel L, Melino G, Kroemer G (2018) Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ 25:486\u2013541. https:\/\/doi.org\/10.1038\/s41418-017-0012-4","journal-title":"Cell Death Differ"},{"key":"4213_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10565-019-09496-2","volume":"36","author":"JG Nirmala","year":"2019","unstructured":"Nirmala JG, Lopus M (2019) Cell death mechanisms in eukaryotes. Cell Biol Toxicol 36:145\u2013164. https:\/\/doi.org\/10.1007\/s10565-019-09496-2","journal-title":"Cell Biol Toxicol"},{"key":"4213_CR15","doi-asserted-by":"publisher","first-page":"7684","DOI":"10.1021\/acs.jmedchem.9b00326","volume":"62","author":"AH Elmenoufy","year":"2019","unstructured":"Elmenoufy AH, Gentile F, Jay D, Karimi-Busheri F, Yang X, Soueidan OM, Weilbeer C, Mani RS, Barakat KH, Tuszynski JA, Weinfeld M, West FG (2019) Targeting DNA repair in tumor cells via inhibition of ERCC1\u2013XPF. J Med Chem 62:7684\u20137696. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00326","journal-title":"J Med Chem"},{"key":"4213_CR16","doi-asserted-by":"publisher","first-page":"112658","DOI":"10.1016\/j.ejmech.2020.112658","volume":"204","author":"AH Elmenoufy","year":"2020","unstructured":"Elmenoufy AH, Gentile F, Jay D, Karimi-Busheri F, Yang X, Soueidan OM, Mani RS, Ciniero G, Tuszynski JA, Weinfeld M, West FG (2020) Design, synthesis and in vitro cell-free\/cell-based biological evaluations of novel ERCC1\u2013XPF inhibitors targeting DNA repair pathway. Eur J Med Chem 204:112658. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112658","journal-title":"Eur J Med Chem"},{"key":"4213_CR17","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1002\/jcc.20933","volume":"29","author":"P Labute","year":"2008","unstructured":"Labute P (2008) The generalized born\/volume integral implicit solvent model: estimation of the free energy of hydration using London dispersion instead of atomic surface area. J Comput Chem 29:1693\u20131698. https:\/\/doi.org\/10.1002\/jcc.20933","journal-title":"J Comput Chem"},{"key":"4213_CR18","first-page":"133","volume":"62","author":"A Volpe","year":"2010","unstructured":"Volpe A, Racioppi M, D\u2019Agostino D, Cappa E, Filianoti A, Bassi PF (2010) Mitomycin C for the treatment of bladder cancer. Minerva Urol Nefrol 62:133\u2013144","journal-title":"Minerva Urol Nefrol"},{"key":"4213_CR19","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/cancers3011351","volume":"3","author":"A-M Florea","year":"2011","unstructured":"Florea A-M, B\u00fcsselberg D (2011) Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects. Cancers (Basel) 3:1351\u20131371. https:\/\/doi.org\/10.3390\/cancers3011351","journal-title":"Cancers (Basel)"},{"key":"4213_CR20","doi-asserted-by":"publisher","first-page":"6645","DOI":"10.1039\/c8dt00838h","volume":"47","author":"R Oun","year":"2018","unstructured":"Oun R, Moussa YE, Wheate NJ (2018) The side effects of platinum-based chemotherapy drugs: a review for chemists. Dalt Trans 47:6645\u20136653. https:\/\/doi.org\/10.1039\/c8dt00838h","journal-title":"Dalt Trans"},{"key":"4213_CR21","doi-asserted-by":"publisher","first-page":"75104","DOI":"10.18632\/oncotarget.12072","volume":"7","author":"S Arora","year":"2016","unstructured":"Arora S, Heyza J, Zhang H, Kalman-Maltese V, Tillison K, Floyd AM, Chalfin EM, Bepler G, Patrick SM (2016) Identification of small molecule inhibitors of ERCC1\u2013XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells. Oncotarget 7:75104\u201375117. https:\/\/doi.org\/10.18632\/oncotarget.12072","journal-title":"Oncotarget"},{"key":"4213_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.dnarep.2015.04.002","volume":"31","author":"EM McNeil","year":"2015","unstructured":"McNeil EM, Astell KR, Ritchie AM, Shave S, Houston DR, Bakrania P, Jones HM, Khurana P, Wallace C, Chapman T, Wear MA, Walkinshaw MD, Saxty B, Melton DW (2015) Inhibition of the ERCC1\u2013XPF structure-specific endonuclease to overcome cancer chemoresistance. DNA Repair (Amst) 31:19\u201328. https:\/\/doi.org\/10.1016\/j.dnarep.2015.04.002","journal-title":"DNA Repair (Amst)"},{"key":"4213_CR23","doi-asserted-by":"publisher","first-page":"11671","DOI":"10.1039\/c9cc05476f","volume":"55","author":"AM Thomas","year":"2019","unstructured":"Thomas AM, Brolih S, McGouran JF, El-Sagheer AH, Ptchelkine D, Jones M, McDonald NQ, McHugh PJ, Brown T (2019) Optimised oligonucleotide substrates to assay XPF-ERCC1 nuclease activity for the discovery of DNA repair inhibitors. Chem Commun 55:11671\u201311674. https:\/\/doi.org\/10.1039\/c9cc05476f","journal-title":"Chem Commun"},{"key":"4213_CR24","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1016\/j.bmcl.2015.08.031","volume":"25","author":"TM Chapman","year":"2015","unstructured":"Chapman TM, Gillen KJ, Wallace C, Lee MT, Bakrania P, Khurana P, Coombs PJ, Stennett L, Fox S, Bureau EA, Brownlees J, Melton DW, Saxty B (2015) Catechols and 3-hydroxypyridones as inhibitors of the DNA repair complex ERCC1\u2013XPF. Bioorgan Med Chem Lett 25:4097\u20134103. https:\/\/doi.org\/10.1016\/j.bmcl.2015.08.031","journal-title":"Bioorgan Med Chem Lett"},{"key":"4213_CR25","doi-asserted-by":"publisher","first-page":"4708","DOI":"10.1021\/bi00069a004","volume":"32","author":"AK Basu","year":"1993","unstructured":"Basu AK, Hanrahan CJ, Malia SA, Kumar S, Bizanek R, Tomasz M (1993) Effect of site-specifically located mitomycin C-DNA monoadducts on in vitro DNA synthesis by DNA Polymerases. Biochemistry 32:4708\u20134718. https:\/\/doi.org\/10.1021\/bi00069a004","journal-title":"Biochemistry"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-020-04213-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-020-04213-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-020-04213-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T21:29:39Z","timestamp":1612906179000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-020-04213-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["4213"],"URL":"https:\/\/doi.org\/10.1007\/s00280-020-04213-x","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,5]]},"assertion":[{"value":"8 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}